With the development of the first GIP/GLP-1 co-agonist, tirzepatide, there has been an exponential increase in the effectiveness of incretin-mimetic pharmacological therapy for weight control in obese patients with and without diabetes
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management (Mounjaro) and chronic weight management (Zepbound)
Laboratories can strengthen interpretability by standardizing preparation methods and documenting core variables such as container material selection, mixing approach, working solution timing, and assay incubation conditions
A Skinny Shots Doctor specializes in advanced vitamin and amino blend injectionsunlike a standalone B12 shot, Dr
For some, it involves medications like Ozempic (semaglutide)
At Infinite You Wellness Clinic in White Plains, our wellness and longevity therapies help you stay ahead of fatigue, inflammation, and age-related changes while supporting energy, mental clarity, and overall health at every stage of life
